Switching to venetoclax led to sustained high rates of undetectable minimal residual disease, the investigators found.

Personalized exercise guidance is needed for people living with chronic lymphocytic leukemia (CLL), the most common type of ...

CLL Society, the world's leading authority for chronic lymphocytic leukemia and small lymphocytic lymphoma patients, has announced the recipients of its 2025 Research Program awards. This year, three ...

Discover how exercise programs and personalized guidance contribute to positive impact on symptoms and quality of life in ...

Personalized exercise guidance is needed for people living with Chronic Lymphocytic Leukemia (CLL), the most common type of ...

Personalised exercise guidance is needed for people living with Chronic Lymphocytic Leukaemia (CLL), the most common type of blood cancer, according to a new study led by the University of Surrey.

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...

A study reveals that venetoclax consolidation after BTKi therapy is effective for chronic lymphocytic leukemia, offering promising outcomes for patients.

Panelist discusses how new all-oral combination regimens are transforming the treatment landscape by addressing unmet needs ...

To combat the onslaught of litigation, Bayer has been pushing legislation in nine states, that would shield the company from ...

At a lymphoma conference, experts sparred about treatment options, while an outside expert highlighted the value of each approach.